Compounds > 4-diphenylacetoxy-1,1-dimethylpiperidinium
Page last updated: 2024-10-21

4-diphenylacetoxy-1,1-dimethylpiperidinium and Pulmonary Disease, Chronic Obstructive

4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies

4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.

Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koarai, A1
Traves, SL1
Fenwick, PS1
Brown, SM1
Chana, KK1
Russell, RE1
Nicholson, AG1
Barnes, PJ1
Donnelly, LE1

Other Studies

1 other study available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Pulmonary Disease, Chronic Obstructive

ArticleYear
Expression of muscarinic receptors by human macrophages.
    The European respiratory journal, 2012, Volume: 39, Issue:3

    Topics: Carbachol; Cells, Cultured; Choline O-Acetyltransferase; Humans; Interleukin-6; Interleukin-8; Leuko

2012